Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells
- 333 Downloads
Extracellular signal-regulated kinase 5 (ERK5), a recently discovered mitogen-activated protein kinase (MAPK), plays a key role in the development and pathogenesis of cardiovascular disease. In order to clarify the pathophysiological significance of ERK5 in vascular remodeling, we investigated ERK5 phosphorylation in hypertrophy of human aortic smooth muscle cells (HASMCs) induced by angiotensin II (Ang II). The AT1 receptor was involved in Ang II-induced ERK5 activity. Hypertrophy was detected by the measurement of protein synthesis with [3H]-Leu incorporation in cultured HASMCs. Ang II rapidly induced phosphorylation of ERK5 at Thr218/Tyr220 residues in a time- and dose-dependent manner. Activation of myocyte enhancer factor-2C (MEF2C) by ERK5 was inhibited by PD98059. Transfecting HASMCs with small interfering RNA (siRNA) to silence ERK5 inhibited Ang II-induced cell hypertrophy. Thus, ERK5 phosphorylation contributes to MEF2C activation and subsequent HASMC hypertrophy induced by Ang II, for a novel molecular mechanism in cardiovascular diseases induced by Ang II.
KeywordsERK5 Hypertrophy Human aortic smooth muscle cells Angiotensin II
We gratefully acknowledge the technical assistance from Dr. Jinbo Feng, and Dr. Guanghui Liu in histopathological and molecular biological analysis. This study was supported by the National 973 Basic Research Program of China (No.2007CB512003) and Natural Fund of Shandong Province (Y2007C012).
- 12.Dong F, Gutkind JS, Larner AC (2001) Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. J Biol Chem 276:10811–10816. doi: 10.1074/jbc.M008748200 PubMedCrossRefGoogle Scholar